If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
559.00    3.00 (0.54%)
Bid:
556.50
Ask:
557.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:31

Tate & Lyle PLC

Notification of transactions by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that it was informed yesterday that transactions occurred by Persons Discharging Managerial Responsibilities (‘PDMR’) in respect of their interests in ordinary shares of 25 pence each in the capital of the Company (‘Shares’) under the 2016 Conditional Share Award programme (‘CSA’).

No consideration was paid for the acquisition of these Shares. Awards made under the CSA were subject to certain Company-based financial performance criteria satisfied over a performance period which ran from 1 April 2016 to 31 March 2017. The Awards were further subject to a 12-month deferral period and continued employment to 31 March 2018.

Following the withholding of Shares to satisfy certain tax obligations arising on the exercise of nil-cost options or the release of Shares, the PDMR’s interests in Shares changed as detailed in the table below:

PDMR   Date of Transaction   No. of Shares acquired under the CSA
Rowan Adams 4 April 2018 25,144
Joan Braca 3 April 2018 37,814
Jim Stutelberg 3 April 2018 25,170

For tax purposes, the market value of the Shares, being the average of the two close prices on the date of the transaction, was 542.4 pence per Share on 4 April 2018 and 537.6 pence per Share on 3 April 2018.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Claire-Marie O’Grady Company Secretary 5 April 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Rowan Adams
2. Reason for the notification
a) Position / status PDMR – Executive Vice President, Corporate Affairs
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the exercise of nil-cost options over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,144

d) Aggregated information

 

Aggregated volume Price

25,144 Nil

 

e) Date of the transaction 2017-04-04
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Joan Braca
2. Reason for the notification
a) Position / status PDMR – President, Speciality Food Ingredients
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 37,814

d) Aggregated information

 

Aggregated volume Price

37,814 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Jim Stutelberg
2. Reason for the notification
a) Position / status PDMR – President, Global Operations
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,170

d) Aggregated information

 

Aggregated volume Price

25,170 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: https://www.businesswire.com/news/home/20180405005843/en/

Copyright Business Wire 2018

Date   Source Headline
4th Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 202412:45 pmRNSTotal Voting Rights
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202411:45 amRNSHolding(s) in Company
25th Mar 202411:45 amRNSHolding(s) in Company
21st Mar 20244:10 pmRNSHolding(s) in Company
20th Mar 20243:00 pmRNSHolding(s) in Company
20th Mar 202412:00 pmRNSHolding(s) in Company
19th Mar 20242:00 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
12th Mar 20244:24 pmRNSHolding(s) in Company
12th Mar 20244:22 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSDirectorate Change
4th Mar 20242:00 pmRNSDirector/PDMR Shareholding
4th Mar 20241:45 pmRNSHolding(s) in Company
28th Feb 20242:30 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSTrading Statement
1st Feb 202412:00 pmRNSTotal Voting Rights
11th Jan 20241:00 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:00 pmRNSBlock listing Interim Review
8th Dec 202311:45 amRNSDirector/PDMR Shareholding
6th Dec 202310:30 amRNSHolding(s) in Company
27th Nov 20234:15 pmRNSHolding(s) in Company
23rd Nov 20232:30 pmRNSHolding(s) in Company
20th Nov 202310:00 amRNSHolding(s) in Company
9th Nov 20237:00 amRNSHalf-year Report
8th Nov 20237:00 amRNSDirectorate Change
23rd Oct 202310:30 amRNSHolding(s) in Company
16th Oct 202310:30 amRNSHolding(s) in Company
13th Oct 202310:30 amRNSHolding(s) in Company
12th Oct 202311:00 amRNSHolding(s) in Company
2nd Oct 202310:23 amRNSDirector Declaration
1st Sep 202311:00 amRNSTotal Voting Rights
25th Aug 20233:45 pmRNSHolding(s) in Company
17th Aug 20234:30 pmRNSHolding(s) in Company
15th Aug 20234:30 pmRNSHolding(s) in Company
10th Aug 20234:00 pmRNSHolding(s) in Company
7th Aug 202312:15 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:45 pmRNSDirector/PDMR Shareholding
2nd Aug 202311:30 amRNSHolding(s) in Company
1st Aug 202311:15 amRNSTotal Voting Rights
28th Jul 202312:00 pmRNSDirector/PDMR Shareholding
27th Jul 20231:15 pmRNSResult of AGM
27th Jul 20239:30 amRNSHolding(s) in Company
26th Jul 202311:30 amRNSHolding(s) in Company
25th Jul 202311:30 amRNSHolding(s) in Company
24th Jul 202312:30 pmRNSHolding(s) in Company
18th Jul 202312:30 pmRNSHolding(s) in Company
4th Jul 20233:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:10 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.